Under Armour reports Tuesday with one of the most heavily shorted setups in the apparel space — and short sellers have been adding, not retreating, in the run-up.
Short interest runs at 24.2% of the free float, a level that places UAA firmly in crowded-short territory. That position has grown roughly 9.4% over the past month and ticked up again in the final week before earnings, reaching 45.7 million shares as of May 7. Days to cover is 6.78 — meaning it would take nearly seven full trading sessions to unwind the short book at average daily volume. Borrowing remains cheap at 0.65%, but availability has tightened: with only around 38% of shares still available to lend, the pool is narrower than at most points this year. The ORTEX short score of 72.8 ranks in the 3rd percentile of all stocks — among the most bearishly positioned names in the universe. Options traders echo the tone. The put/call ratio of 1.90 is well above the broader market norm, though it has actually eased slightly from highs seen in late April, and the z-score of 0.43 suggests the defensive posture is persistent rather than panicked — this has become the baseline.
The bull and bear cases are in genuine disagreement about whether a turnaround is taking shape. Bears point to ongoing headwinds: supply chain friction, margin pressure from promotions, and an international revenue mix that remains volatile. Competition from better-resourced rivals and a history of missed growth targets undercut confidence in management's ability to execute. Bulls counter that the company has taken real action — SKU rationalization, raw material procurement efficiencies, and raised EPS guidance despite falling overall revenue — arguing that the self-help story is progressing even if the top line is still shrinking. Analyst moves from February, following the last earnings release, were cautiously constructive: Goldman Sachs lifted its target to $7.00 from $5.50 and Barclays moved to $8.00 from $5.00, both maintaining neutral-equivalent ratings. Citigroup moved the other direction, downgrading to Sell after the same print. The consensus sits at "buy" with five positive ratings, but the stock at $6.43 trades below Goldman's $7.00 target and below Barclays' $8.00 — suggesting the Street sees modest upside, not a breakout.
The ownership picture adds an intriguing layer. Fairfax Financial — the Canadian insurer run by Prem Watsa — built a 15.3% stake in a series of open-market purchases between late December 2025 and late January 2026, spending over $116 million net across that period and now sitting as the largest outside institutional holder alongside BDT Capital. BlackRock also added 7.5 million shares through April, bringing its holding to 8.8% of shares outstanding. Founder Kevin Plank remains at 13.1%. That ownership cluster — a concentrated value-oriented anchor investor, passive giants adding on dips, and a founder still invested — describes a stock that its biggest holders believe is cheap, even as short sellers press their thesis. The prior print in February delivered a striking data point: the stock jumped 25% on the day and held most of those gains over the following five sessions, suggesting the market was badly positioned for positive news.
Tomorrow's print is a direct test of whether the cost-reduction story is translating into durable margin improvement — or whether the headline EPS beats are masking continued erosion in brand strength and revenue trajectory.
See the live data behind this article on ORTEX.
Open UAA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
